Upgrade to SI Premium - Free Trial

WAVE Life Sciences (WVE) PT Lowered to $39 at Clear Street, 'we think ‘007 should find its optimal patient population'

March 26, 2026 4:21 PM
Clear Street analyst Bill Maughan lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $39.00 (from $50.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles